Cognetivity Neurosciences Ltd.
CGNSF
$0.01
$0.000.00%
| Weiss Ratings | CGNSF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Unrated | |||
| Risk Index | Unrated | |||
| Risk Grade | U | |||
| Reward Grade | U | |||
| Rating Factors | CGNSF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | Unrated | |||
| Growth Index | Unrated | |||
| Efficiency Index | Unrated | |||
| Solvency Index | Unrated | |||
| Total Return Index | Unrated | |||
| Volatility Index | Unrated | |||
| Beta / Standard Deviation | CGNSF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 1.88 | |||
| Price History | CGNSF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 56.25% | |||
| 30-Day Total Return | 42.86% | |||
| 60-Day Total Return | 150.00% | |||
| 90-Day Total Return | 75.44% | |||
| Year to Date Total Return | 185.71% | |||
| 1-Year Total Return | -27.01% | |||
| 2-Year Total Return | -96.10% | |||
| 3-Year Total Return | -96.72% | |||
| 5-Year Total Return | -86.67% | |||
| 52-Week High % Change | -56.14% | |||
| 52-Week Low % Change | 809.09% | |||
| Price | CGNSF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $0.02 | |||
| 52-Week Low Price | $0.00 | |||
| 52-Week Low Price (Date) | Jul 25, 2024 | |||
| 52-Week High Price (Date) | Apr 09, 2024 | |||
| Valuation | CGNSF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 648.02K | |||
| Enterprise Value | 7.34M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -0.07 | |||
| Earnings Per Share Growth | -25.55% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 12.50 | |||
| Price/Book (Q) | -0.08 | |||
| Enterprise Value/Revenue (TTM) | 100.27 | |||
| Price | $0.01 | |||
| Enterprise Value/EBITDA (TTM) | -2.35 | |||
| Enterprise Value/EBIT | -2.33 | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | CGNSF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 88.37M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | CGNSF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | -- | |||
| Address | 1055 West Hastings Street Vancouver, BC V6E 2E9 | |||
| Website | cognetivity.com | |||
| Country | Canada | |||
| Year Founded | 2015 | |||
| Profitability | CGNSF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -4,295.64% | |||
| Profit Margin | -8,718.63% | |||
| Management Effectiveness | CGNSF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -97.42% | |||
| Return on Equity | -- | |||
| Income Statement | CGNSF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 73.50K | |||
| Total Revenue (TTM) | 73.50K | |||
| Revenue Per Share | $0.00 | |||
| Gross Profit (TTM) | -937.10K | |||
| EBITDA (TTM) | -3.14M | |||
| EBIT (TTM) | -3.16M | |||
| Net Income (TTM) | -6.41M | |||
| Net Income Avl. to Common (TTM) | -6.41M | |||
| Total Revenue Growth (Q YOY) | -- | |||
| Earnings Growth (Q YOY) | -11.15% | |||
| EPS Diluted (TTM) | -0.07 | |||
| EPS Diluted Growth (Q YOY) | 0.00% | |||
| Balance Sheet | CGNSF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 11.90K | |||
| Cash Per Share (Q) | $0.00 | |||
| Total Current Assets (Q) | 218.30K | |||
| Total Preferred Equity (Q) | 5.99 | |||
| Total Equity (Q) | -4.95M | |||
| Current Ratio (Q) | 0.041 | |||
| Book Value Per Share (Q) | -$0.12 | |||
| Total Assets (Q) | 350.40K | |||
| Total Current Liabilities (Q) | 5.30M | |||
| Total Debt (Q) | 985.00K | |||
| Total Liabilities (Q) | 5.30M | |||
| Total Common Equity (Q) | -10.94M | |||
| Cash Flow | CGNSF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -17.90K | |||
| Cash from Financing (TTM) | -169.80K | |||
| Net Change in Cash (TTM) | -3.05M | |||
| Levered Free Cash Flow (TTM) | -1.97M | |||
| Cash from Operations (TTM) | -2.86M | |||
